Price, T J
Bruhn, M A
Lee, C K
Hardingham, J E
Townsend, A R
Mann, K P
Simes, J
Weickhardt, A
Wrin, J W
Wilson, K
Gebski, V
Van Hazel, G
Robinson, B
Cunningham, D
Tebbutt, N C
Article History
First Online: 5 March 2015
Competing interests
: TJ Price: advisory board Roche, Merck, AMGEN; G Van Hazel: advisory board Roche; D Cunningham: research funding Roche; NC Tebbutt, advisory board Roche. The other authors declare no conflict of interest.